Lisbet Ambrosius Christensen

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 451 citations

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study

Søren Peter Jørgensen, Jørgen Agnholt, Henning Glerup et al. · Alimentary Pharmacology & Therapeutics · 2010 · 377 citations · Full text

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter G. Gibson et al. · Gastroenterology · 2016 · 321 citations · Full text

Inflammation, Rheumatology, Maternal Immunization +7

pH‐Profile and regional transit times of the normal gut measured by a radiotelemetry device

Jan Fallingborg, Lisbet Ambrosius Christensen, Margrethe Ingeman‐Nielsen et al. · Alimentary Pharmacology & Therapeutics · 1989 · 235 citations

Very low intraluminal colonic pH in patients with active ulcerative colitis

Jan Fallingborg, Lisbet Ambrosius Christensen, Bent Ascanius Jacobsen et al. · Digestive Diseases and Sciences · 1993 · 224 citations

Functional Gastrointestinal Disorder, Gastroenterology, Pathology +4